989 related articles for article (PubMed ID: 19406269)
1. Effects of left ventricular volume overload on mitochondrial and death-receptor-mediated apoptotic pathways in the transition to heart failure.
Moorjani N; Westaby S; Narula J; Catarino PA; Brittin R; Kemp TJ; Narula N; Sugden PH
Am J Cardiol; 2009 May; 103(9):1261-8. PubMed ID: 19406269
[TBL] [Abstract][Full Text] [Related]
2. Activation of apoptotic caspase cascade during the transition to pressure overload-induced heart failure.
Moorjani N; Ahmad M; Catarino P; Brittin R; Trabzuni D; Al-Mohanna F; Narula N; Narula J; Westaby S
J Am Coll Cardiol; 2006 Oct; 48(7):1451-8. PubMed ID: 17010810
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure.
Li XM; Ma YT; Yang YN; Liu F; Chen BD; Han W; Zhang JF; Gao XM
Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1054-61. PubMed ID: 19566828
[TBL] [Abstract][Full Text] [Related]
4. [Effect of beta3-adrenoreceptors agonist on beta3-adrenoreceptors expression and myocyte apoptosis in a rat model of heart failure].
Kong YH; Li WM; Tian Y
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Mar; 16(3):142-7. PubMed ID: 15009959
[TBL] [Abstract][Full Text] [Related]
5. Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lung.
Shabnam MS; Srinivasan R; Wali A; Majumdar S; Joshi K; Behera D
Lung Cancer; 2004 Aug; 45(2):181-8. PubMed ID: 15246189
[TBL] [Abstract][Full Text] [Related]
6. Left ventricular wall stress as a direct correlate of cardiomyocyte apoptosis in patients with severe dilated cardiomyopathy.
Di Napoli P; Taccardi AA; Grilli A; Felaco M; Balbone A; Angelucci D; Gallina S; Calafiore AM; De Caterina R; Barsotti A
Am Heart J; 2003 Dec; 146(6):1105-11. PubMed ID: 14661007
[TBL] [Abstract][Full Text] [Related]
7. Contribution of non-cardiomyocyte apoptosis to cardiac remodelling that occurs in the transition from compensated hypertrophy to heart failure in spontaneously hypertensive rats.
Ikeda S; Hamada M; Hiwada K
Clin Sci (Lond); 1999 Aug; 97(2):239-46. PubMed ID: 10409480
[TBL] [Abstract][Full Text] [Related]
8. Relationship between cardiomyocyte cell death and cardiac function during hypertensive cardiac remodelling in Dahl rats.
Ikeda S; Hamada M; Qu P; Hiasa G; Hashida H; Shigematsu Y; Hiwada K
Clin Sci (Lond); 2002 Mar; 102(3):329-35. PubMed ID: 11869174
[TBL] [Abstract][Full Text] [Related]
9. Dose and time-dependent apoptotic effects by angiotensin II infusion on left ventricular cardiomyocytes.
Fabris B; Candido R; Bortoletto M; Zentilin L; Sandri M; Fior F; Toffoli B; Stebel M; Bardelli M; Belgrado D; Giacca M; Carretta R
J Hypertens; 2007 Jul; 25(7):1481-90. PubMed ID: 17563572
[TBL] [Abstract][Full Text] [Related]
10. Cardiomyocyte desmin abnormalities - an accurate predictor of long-term survival in patients with chronic heart failure.
Pawlak A; Gil RJ; Kasprzak J; Walczak E; Słysz A
Kardiol Pol; 2009 Jul; 67(7):724-33. PubMed ID: 19649994
[TBL] [Abstract][Full Text] [Related]
11. Human hibernating myocardium is jeopardized by apoptotic and autophagic cell death.
Elsässer A; Vogt AM; Nef H; Kostin S; Möllmann H; Skwara W; Bode C; Hamm C; Schaper J
J Am Coll Cardiol; 2004 Jun; 43(12):2191-9. PubMed ID: 15193679
[TBL] [Abstract][Full Text] [Related]
12. Distinct myocardial effects of beta-blocker therapy in heart failure with normal and reduced left ventricular ejection fraction.
Hamdani N; Paulus WJ; van Heerebeek L; Borbély A; Boontje NM; Zuidwijk MJ; Bronzwaer JG; Simonides WS; Niessen HW; Stienen GJ; van der Velden J
Eur Heart J; 2009 Aug; 30(15):1863-72. PubMed ID: 19487234
[TBL] [Abstract][Full Text] [Related]
13. Myocardial cytokine gene expression is higher in aortic stenosis than in idiopathic dilated cardiomyopathy.
Vanderheyden M; Paulus WJ; Voss M; Knuefermann P; Sivasubramanian N; Mann D; Baumgarten G
Heart; 2005 Jul; 91(7):926-31. PubMed ID: 15958363
[TBL] [Abstract][Full Text] [Related]
14. Programmed cell death in idiopathic dilated cardiomyopathy is mediated by suppression of the apoptosis inhibitor Apollon.
Aharinejad S; Andrukhova O; Lucas T; Zuckermann A; Wieselthaler G; Wolner E; Grimm M
Ann Thorac Surg; 2008 Jul; 86(1):109-14; discussion 114. PubMed ID: 18573408
[TBL] [Abstract][Full Text] [Related]
15. Activation of apoptotic pathways in experimental acute afterload-induced right ventricular failure.
Dewachter C; Dewachter L; Rondelet B; Fesler P; Brimioulle S; Kerbaul F; Naeije R
Crit Care Med; 2010 Jun; 38(6):1405-13. PubMed ID: 20431484
[TBL] [Abstract][Full Text] [Related]
16. Programmed cell death (apoptosis) as a possible pathway to metalloproteinase activation and fetal membrane degradation in premature rupture of membranes.
Fortunato SJ; Menon R; Bryant C; Lombardi SJ
Am J Obstet Gynecol; 2000 Jun; 182(6):1468-76. PubMed ID: 10871467
[TBL] [Abstract][Full Text] [Related]
17. Radiation therapy induced changes in apoptosis and its major regulatory proteins, Bcl-2, Bcl-XL, and Bax, in locally advanced invasive squamous cell carcinoma of the cervix.
Adhya AK; Srinivasan R; Patel FD
Int J Gynecol Pathol; 2006 Jul; 25(3):281-7. PubMed ID: 16810067
[TBL] [Abstract][Full Text] [Related]
18. The cellular and physiologic effects of beta blockers in heart failure.
Sabbah HN
Clin Cardiol; 1999 Oct; 22 Suppl 5():V16-20. PubMed ID: 10526699
[TBL] [Abstract][Full Text] [Related]
19. Cardiac molecular markers of programmed cell death are activated in end-stage heart failure patients supported by left ventricular assist device.
Prescimone T; Masotti S; D'Amico A; Caruso R; Cabiati M; Caselli C; Viglione F; Verde A; Del Ry S; Giannessi D
Cardiovasc Pathol; 2014; 23(5):272-82. PubMed ID: 24856512
[TBL] [Abstract][Full Text] [Related]
20. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
